The global autotransfusion devices market was valued at US$ 1.1 billion in 2021 and is expected to grow at a CAGR of 5.2% through 2032.
Autotransfusion devices are widely used to collect and reinfuse the patient’s blood back into the body. This type of practice plays a major role in cell-building techniques of the human body, it enables autologous blood transfusion, and most importantly it reduces the different risks related to immunologically incompatible blood transfusion. They are widely used in cardiovascular, orthopedic, neurological, and several gynecological surgeries.
Market Overview-
The major reason for the rise in the autotransfusion devices market is due to the increasing number of surgical procedures and the prevalence of chronic diseases in the market.
Market Drivers-
Cardiac Surgeries are one of the primary reasons for the rise in the manufacturing of the Autotransfusion devices market. According to the World Health Organization, cardiac diseases and cardiac attacks are the number one reason for the cause of deaths globally. Also, the requirement is increasing due to the shortage of donated blood.
Geographical Distribution of the Autotransfusion Auto Transfusion Market-
North America dominates the Auto Transfusion Market due to multiple factors such as the presence of top companies in the region, a high number of surgeries taking place in this region, availability of advanced healthcare infrastructure, and also beneficial government initiatives which are also the primary factor for the dominance of North American market.
Europe and Asia-Pacific follow North America, region. In the European market rapidly increasing surgeries especially in the UK, France, and Germany with a strong focus on intraoperative techniques is expected to surge the demand for autotransfusion devices.
Asia-Pacific region is expected to record the highest CAGR, due to the entry of new companies during the forecast period. Also, another factor contributing to the growth is the rapidly increasing number of surgeries, and developing healthcare infrastructure is a bolster for the supplies of Auto Transfusion devices.
Global Autotransfusion Devices Market- Share Analysis, by Geography (2021)
The report titled “Global Autotransfusion Devices Market- Global Market Share, Trends, Analysis and Forecasts, 2022-2032” offers market estimates for a period 2022 to 2032, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Autotransfusion Devices Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
In terms of revenue generation the cardiovascular segment dominates the market, the reason being the highest utilization of these devices during the various cardiovascular procedures.
End-User Analysis:
The hospital segment is going to be the dominant segment during the forecast period with the increasing number of cardiovascular surgeries taking place. Cardiovascular organ transplantation also occupies an important place in the end-user analysis in the market as this branch is traditionally associated with blood loss and subsequently requires a high level of blood transfusion.
The report on autotransfusion devices market presents us with an accurate analysis of the market giving a holistic picture of the upcoming market performance, the top industry players, and the region level distribution of the product.
The leading players in this market include Medtronic Plc, Zimmer Biomet Holdings, Liva Nova, Atrium Medical Corporation, ZKSK Technology, Gen World Medical Devices among others.
Market segmentation
By Product type
By Application type
By End-User
By Geography
The global market for Autotransfusion Devices will most likely expand at over XX% CAGR through 2032.
Cardiac Surgeries are one of the primary reasons for the rise in the manufacturing of the Autotransfusion Auto Transfusion devices market. According to the World Health Organization, cardiac diseases and cardiac attacks are the number one reason for the cause of deaths globally. Also, the requirement is increasing due to the shortage of donated blood.
Based on type, the Autotransfusion Devices market is segmented into Autotransfusion systems (Intraoperative, Postoperative, Dual Mode Autotransfusion), Consumables and Accessories.
Medtronic Plc, Zimmer Biomet Holdings, Liva Nova, Atrium Medical Corporation, ZKSK Technology are the top 5 Autotransfusion Devices manufacturers.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved